Free Trial
NASDAQ:MASS

908 Devices Q3 2025 Earnings Report

908 Devices logo
$8.86 -0.13 (-1.39%)
As of 01:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

908 Devices EPS Results

Actual EPS
N/A
Consensus EPS
-$0.12
Beat/Miss
N/A
One Year Ago EPS
N/A

908 Devices Revenue Results

Actual Revenue
N/A
Expected Revenue
$13.58 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

908 Devices Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Tuesday, November 11, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

908 Devices Earnings Headlines

If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of customer deposits as Americans rush into a new form of money… That’s just been authorized under President Trump’s highly controversial new law, S.1582.tc pixel
See More 908 Devices Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 908 Devices? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 908 Devices and other key companies, straight to your email.

About 908 Devices

908 Devices (NASDAQ:MASS) Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations. These platforms are designed to offer fast sample-to-answer workflows with integrated data analysis software.

Founded in 2004 and headquartered in Boston, Massachusetts, 908 Devices leverages its proprietary micro-engineering and analytical expertise to serve customers around the world. The company’s instruments are employed across North America, Europe, Asia and other regions through a combination of direct sales, channel partners and strategic alliances.

The company’s solutions support a variety of applications, including security and defense screening, forensic investigations, environmental monitoring, pharmaceutical quality control and food safety testing. By providing real-time chemical intelligence at the point of need, 908 Devices aims to enhance operational efficiency and safety for government agencies, research institutions and commercial laboratories.

View 908 Devices Profile

More Earnings Resources from MarketBeat